Comparison of Safety and Resulting Blood Level Profiles After Administration of a New Boceprevir Tablet Versus Its Current Capsule Formulation for Treatment of Chronic Hepatitis C (P06992)(COMPLETED)

Name: Comparison of Safety and Resulting Blood Level Profiles After Administration of a New Boceprevir Tablet Versus Its Current Capsule Formulation for Treatment of Chronic Hepatitis C (P06992)(COMPLETED)
Published: 2010
License: Public Domain

Merck Sharp & Dohme LLC · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

hepatitis-c

hepatitis c, boceprevir, bioequivalence, sch 503034, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Comparison of Safety and Resulting Blood Level Profiles After Administration of a New Boceprevir Tablet Versus Its Current Capsule Formulation for Treatment of Chronic Hepatitis C (P06992)(COMPLETED)

Related documents